Inmagene Announces Three Presentations at the 2024 European Academy of Dermatology and Venereology Congress
San Diego, CA, September 20, 2024 – Inmagene Biopharmaceuticals (“Inmagene” or the “Company”), a clinical stage biotechnology company developing innovative […]